» Articles » PMID: 6241952

Detection of Terminal Complement Components in Experimental Immune Glomerular Injury

Overview
Journal Kidney Int
Publisher Elsevier
Specialty Nephrology
Date 1984 Dec 1
PMID 6241952
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Complement mediates glomerulonephritis by inflammatory cell-dependent and non-inflammatory cell-independent effects on glomerular permeability. The latter may involve terminal components of the complement system. We examined several models of immunologic renal injury in the rat by immunofluorescence (IF) for terminal complement components C5, C6, C7, and C8 in glomeruli using antisera to human C5-8, which cross-react with the analogous rat complement components. Rats with the heterologous and autologous phases of passive Heymann nephritis (PHN) had proteinuria and 1 to 2+ capillary wall deposits of heterologous or rat IgG, rat C3, and C5-8. Complement depletion with cobra venom factor (CVF) significantly decreased proteinuria in both models and prevented deposition of all complement components. Rats with active Heymann nephritis had similar deposits of rat IgG and C5-8. Rats with anti-GBM nephritis and aminonucleoside nephrosis had severe proteinuria which was not affected by CVF treatment and deposits of C5-8 were absent. The presence of terminal complement components in immune deposits in experimental glomerular disease correlates with a functional role for complement in mediating glomerular injury. These data support the hypothesis that the terminal complement pathway may be a major mediator of some types of immune glomerular injury.

Citing Articles

The Immunobiological Agents for Treatment of Antiglomerular Basement Membrane Disease.

Yamashita M, Takayasu M, Maruyama H, Hirayama K Medicina (Kaunas). 2023; 59(11).

PMID: 38004064 PMC: 10673378. DOI: 10.3390/medicina59112014.


Membranous nephropathy: Clearer pathology and mechanisms identify potential strategies for treatment.

Chung E, Wang Y, Keung K, Hu M, McCarthy H, Wong G Front Immunol. 2022; 13:1036249.

PMID: 36405681 PMC: 9667740. DOI: 10.3389/fimmu.2022.1036249.


Identification and characterization of a new autoimmune protein in membranous nephropathy by immunoscreening of a renal cDNA library.

Cavazzini F, Magistroni R, Furci L, Lupo V, Ligabue G, Granito M PLoS One. 2012; 7(11):e48845.

PMID: 23144993 PMC: 3493607. DOI: 10.1371/journal.pone.0048845.


Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy.

Murtas C, Bruschi M, Candiano G, Moroni G, Magistroni R, Magnano A Clin J Am Soc Nephrol. 2012; 7(9):1394-400.

PMID: 22773590 PMC: 3430946. DOI: 10.2215/CJN.02170312.


Autoimmunity in membranous nephropathy targets aldose reductase and SOD2.

Prunotto M, Carnevali M, Candiano G, Murtas C, Bruschi M, Corradini E J Am Soc Nephrol. 2010; 21(3):507-19.

PMID: 20150532 PMC: 2831859. DOI: 10.1681/ASN.2008121259.